Scandura, J. M., Roboz, G. J., Moh, M., Morawa, E., Brenet, F., Bose, J. R., . . . Feldman, E. J. (2011). Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. American Society of Hematology.
Chicago Style CitationScandura, Joseph M., et al. Phase 1 Study of Epigenetic Priming With Decitabine Prior to Standard Induction Chemotherapy for Patients With AML. American Society of Hematology, 2011.
Cita MLAScandura, Joseph M., et al. Phase 1 Study of Epigenetic Priming With Decitabine Prior to Standard Induction Chemotherapy for Patients With AML. American Society of Hematology, 2011.
Atenció: Aquestes cites poden no estar 100% correctes.